Introduction 62
Vaccines remains an important and mainstay in preventing infectious diseases (Bachler et al. 63 2013; Perrie et al. 2007 ; Black et al. 2010 ). Most of the presently licensed vaccine(s) involve 64 deliberate administration of attenuated or killed pathogen (Shams 2005) . Conventional vaccine 65 development regime involved mass culture of an associated or closely related organism and this 66 hampered vaccine development against important infectious diseases including malaria and 67 leprosy (Scollard et al. 2006; Cox 1991) . Apart from that, conventional vaccines suffered from 68 various issues neatly summarized elsewhere (Pastoret 1999 Apart from that, continuous maintenance of 2-8 °C cold chain from point of manufacturing unit 87 till endpoint user especially in resource-poor settings is a big challenge in presently available 88 vaccines (Chen et al. 2011 , Das 2004 . 89
Issues associated with conventional and peptide-based vaccine lead to the development of a 90 novel strategy of using yeast in vaccine development which culminates into the use of whole 91 recombinant yeast (WRY) and yeast display (YD). Use of WRY and YD proved much better as 92 4 these strategies do not involve protein purification, the addition of protein stabilizers and 93 adjuvant (as yeast cell wall acts as natural adjuvant), particulate nature of yeast cells. Apart from 94 that, yeast cells are efficiently taken-up by antigen presenting cells (APCs) including 95 macrophages (Stubbs et al. 2001) (Shibasaki et al. 2016) . All these and similar studies from 104 different labs across the globe clearly showed the merits and benefits of using WRY and YD as 105 yeast-based vaccines over conventional or peptide-based vaccines. 106 Despite the positive results from different labs against different infectious diseases and cancer a 107 systematic study investigating long-term stability of protein antigens or immunogen in WRY is 108 missing. This compelled us to investigate the long-term stability of heterologous proteins or 109 antigens in the cellular environment of budding yeast. Our present data showed that protein 110 antigens remain stable in yeast cells for up to a year when kept under refrigeration (i.e. at 2-8 °C) 111 and room temperature (i.e. at 23-25°C). We further compared the level of heterologous protein 112 antigens in stationary phased yeast cells kept at 2-8 °C and 23-25°C and present data showed that 113 yeast cells kept under refrigeration condition were better in keeping the protein antigens. 114
Western blot data was further confirmed by iTRAQ based quantitative proteomics which also 115 showed a differential abundance of CsgA in whole cell lysates from cells stored at room 116 temperature and under refrigerated condition. Surprisingly a minor fraction of cells remains 117 viable even after a year in absence of nutrients, which means that it is important to use yeast 118 strain which can enter into stationary phase, can remain intact but did not grow when came into a 119 nutrient-rich niche like host body. 120
Material and methods 121
Strains, media and culture condition 122 Next day, overnight grown culture was used to inoculate 50 mL YPD such that initial OD 600nm 139 was 0.2. Flasks were then incubated at 30 ºC; 250 rpm till growth ceased by checking OD 600nm of 140 culture by spectrophotometer at regular interval of 24 hour. The culture was regularly checked 141 for any contamination and cell morphology. 142
Protein extraction 143
A known number of cells were re-suspended in TCA (tri chloro acetic acid) such that final 144 concentration of TCA was 20 % and cells were frozen at -80 °C for at least one-hour. After one-145 hour tubes were taken out of deep the freezer and thawed at room temperature. Tubes were 146 centrifuged at 14000g for 8-10 min and the supernatant was discarded. Resulted pellet was 147 resuspended in 1 mL chilled 100 % acetone using sonicator. Tubes were again centrifuged as 148 above, and the supernatant was again discarded, and protein pellet was air dried and re-149 suspended in protein solubilization buffer (7 M Urea, 2 M Thiourea, 4 % CHAPS) (Reddy et al. 150 2013) . 151
Western blots 152
Western blot was performed as described previously ( 
Fluorescence microscopy 163
All the images were captured using Zeiss Axio vision microscope using appropriate filters. 164
Accession number 165
Gene cloned in this study was deposited in Gene bank with following accession number 166 MH264502 167
RESULTS 168
The basic logic behind the study and workflow 169
Over the last two to three decades, more than four hundred of papers (including research articles, 170 reviews, case reports) appears which showed the utility of yeast species for expression and 171 Further to make the process more rapid, robust and to cut down the cost involved in protein 176 purification, use of whole recombinant yeast and yeast display appeared promising. Many labs 177 already showed the usefulness of whole recombinant yeast and yeast display in development of a 178 yeast-based vaccine(s). But the long-term stability of expressed immunogen (both in whole 179 recombinant yeast and yeast display) remains elusive. Further, a systematic study evaluating the 180 effect of temperature on the long-term stability (here stability means the complete amino acid 181 sequence of the expressed protein) of heterologous proteins is also missing. 182
Therefore, in the present study, I investigate the stability of heterologous protein viz major curlin 183 (E. coli surface protein, CsgA-GFP) in the cellular environment of S. cerevisiae (with the 7 assumption that cellular environment will be the most suitable environment for the long-term 185 stability of protein). I further study the effect of temperature on the long-term stability of 186 heterologous protein as antigen and the basic workflow of the present study are shown in figure  187 1. 188
The reason for using stationary phase cells are 1) it allows complete utilization of nutrients and 189 harvesting of a large number of cells compared to the culture at mid-log or pre-stationary phase 190 and 2) normal cycling cells cannot be stored at room temperature for a long time let say one year 191 or more and finally 3) stationary phase cells are better in coping the temperature fluctuations 192 which is important in the stability of expressed antigen(s) or immunogen(s). 
Stability of CsgA-GFP fusion protein 235
From each of three flasks, 1 mL cell suspension was transferred into separate sterile eppendrof 236 tubes such that each tube received around 13 OD 600nm of yeast cells. After dispensing cell 237 suspension half tubes were stored at 2-8 °C and remaining half at 23-25 °C. Then after every one 238 month, three tubes each from 2-8 °C and 23-25°C were taken out and OD 600nm were measured till 239 the end of 12 months. Measurement of OD 600nm over the year showed that there is a gradual 240 decrease in OD 600nm (Fig. 4A ), suggesting the cells may be dying. At the end of the one-year 241 final, OD of cells in tubes comes down close to 4.0. In figure, 4A data is shown only for one set, 242 while the experiment was performed thrice, and all three set followed the same trend. 243
Further, it was observed that pace with which OD 600nm decreases was more in tubes stored at 23-244 25 °C compared to those stored at 2-8 °C although the difference in OD 600nm after one year was 245 not that much significant. Apart from that we also observed the sharp difference in cell 246 9 morphology after one year (Fig. 4B ). The morphology of cells stored under refrigerated 247 condition ( Fig. 4B middle panel) was more like to normal cycling cells used as control ( Fig. 4B  248 left panel) compared to those stored at room temperature for a year (Fig. 4B right panel) . Present 249 microscopic data showed that more number of cells lose their intact nature when stored at room 250 temperature. 251
After observing and comparing the morphology of cells stored at two different conditions, we 252 check the level of the CsgA-GFP fusion protein in those cells by western blot. Protein in whole 253 the cell lysate was extracted as described in material and methods and proteins were resolved on 254 10 % SDS-PAGE. Proteins were transferred on to PVDF membrane and the fusion protein was 255 detected using anti-GFP antibodies (Fig. 4C, D) . Present western blot data showed that stationary 256 phase yeast cells were able to keep fusion protein (CsgA-GFP or curlin) intact for a period of one 257
year under both the conditions of storage. To give an idea about the nature of whole cell lysate, 258 the complete image of Ponceau S stained blot is also provided below their respective western 259 blot image (Fig. 4E , F for blot image shown in Fig. 4C, D respectively) . 260
The intensity of bands in western blot image in Fig. 4C were stored at room temperature (Fig. 5D ). Present iTRAQ data also confirmed and validated the 278 western blot data. Just like western blot iTRAQ based quantitative analysis also showed an 279 increased amount of curlin protein (Fig. 5C ) in whole cell lysate from cells stored under 280 refrigerated condition compared to those stored at room temperature. In the present study, cell 281 lysate from refrigerated cells was labelled with 115,117 and those at room temperature with 114, 282 116 labels. It is important to mention that essentially same whole cell lysate was used in both 283 western blots and in the iTRAQ experiment. 284 I further compare the level of CsgA-GFP using western blot after normalizing protein on basis of 285 protein quantification (like the iTRAQ experiment, mentioned above) and results of western blot 286 are in accordance with iTRAQ data (data not shown). 287
Viability of stationary phase cells 288
Studies from different labs in past and our own previous study (Kumar et al. 2016) showed that 289 stationary phase yeast cells retain the viability for extended periods even in absence of nutrients; 290 therefore I further checked the viability of cells after one year. Cell viability was checked by 291 plating around 300 cells on YPD plates. The platting assay showed that almost all cells lose 292 viability after one year irrespective of the temperature of incubation or storage (Fig. 6A, B) . 293
Results of platting assay were further confirmed by checking the viability by trypan blue staining 294 and results of trypan blue staining are in accordance with that of platting assay (Fig. 6C) . In 295 another set of experiment, the whole content of tubes (three tubes each from refrigerated 296 condition and from room temperature) was plated on fresh YPD plates and this time we got a 297 huge number of colonies, suggesting a significant number of cells retain viability even after one 298
year in absence of nutrients (data not shown). In general, peptide-based vaccines overcome many issues associated with the conventional 308 regime of vaccine development as mentioned in the introduction section. But peptide-based 309 vaccines are far away from ideal one and stability of peptide immunogens is an important 310 concern and challenge. Although very few studies are available which assess the effect of 311 temperature on long-term storage of peptide vaccines. For example, a peptide retains its 312 conformation for a week when incubated at 45°C. ESAT651-70-Q11 showed strong 313 immunogenic response even after storage at 45 °C for up to 6 months (Sun et al, 2016) . Still the study which investigates the stability of heterologous protein in WRY for period of year 337 or longer was still missing and therefore this present work tried to fill that important gap in our 1 2 understanding related to effect of temperature on morphology of yeast cells, stability and level of 339 heterologous proteins in cellular environment of yeast over a period of a year. Although present 340 study showed that the heterologous protein expressed in yeast remain intact but make no 341 comment about the actual amount of antigens that remain in total cell mass even after one year 342 (logic for checking stability is shown through figure 7A ). As far as the amount of expressed 343 protein is concerned, incorporating the multi-copy of heterologous genes as described elsewhere 344 (Moon et al. 2016 ) can take care of this. An important issue which needs to be addressed is 345 whether the level of antigens which remain in yeast cells (over a period of 1-2 years at the 346 different temperature) will be able to raise an optimum immune response. The number of cells 347 that need to be stored at the first hand so that enough amount of antigens remains even after a 348
year of storage for optimum immune response need to be workout. But present study clearly 349 makes a point that WRY based vaccine can be transported and distributed even in absence of Since few stationary phase cells remain viable even in absence of nutrients, therefore, it is 365 important to use right yeast strains which are able to enter into stationary phase or G 0 phase for 366 the long-term stability of immunogen but does not grow on providing nutrients or after 367 administration into subjects. Further, it is known that the magnitude of immune response 368 mounted by the application of whole recombinant yeast is independent of the status of yeast cells 1 3 i.e. whether cells are viable or dead (Franzusoff et al. 2005) . Growing of yeast cells to stationary 370 phase rather than till log or mid-log phase is also advantageous from the commercial point of 371 view as more number of cells or biomass can be generated from given volume of media. This 372 will further help in lower down the cost of the vaccine. 373
In conclusion, it can be said that soon yeast-based vaccine will be a reality and strategy like 374 WRY and YD will be really crucial in realizing the full potential of the yeast-based vaccine. The 375 cellular environment of yeast appears suitable for keeping the immunogen intact for a long 376 period when stored under a refrigerated condition or at room temperature. Since OD of cells 377 decreases over period storage, it is important to study whether the amount of immunogen in cells 378 will be enough to raise a required immune response. But results of present work will surely 379 encourage more studies in this direction and it will be further interesting to study the stability of 380 expressed immunogen at an elevated temperature close to 37-43 °C which is common in tropical 381 countries of Africa and Asia which require vaccine badly. Again, it will be of utmost importance 382 to finding out the ways to store immunogen in the cellular environment for at least 1-2 years 383 even when cells are stored at elevated temperature (37-43 °C). But present study clearly showed 384 that WRY based vaccine can be transported even under the normal condition without the need 385 for a continuous chain of refrigeration which is itself of great importance. 
